Johnson & Johnson (JNJ) Invested Capital (2009 - 2026)

Johnson & Johnson has disclosed Invested Capital across 18 years of filings, most recently posting $145.7 billion for Q2 2026.

• In Q2 2026, Invested Capital rose 3.51% year-over-year to $145.7 billion; the TTM figure through Jun 2026 stood at $145.7 billion (up 3.51% YoY), while the FY2025 annual figure was $138.0 billion, up 19.09% from the prior year.
• Invested Capital came in at $145.7 billion for Q2 2026 at Johnson & Johnson, down from $153.6 billion in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $153.6 billion in Q1 2026 to a low of $103.0 billion in Q4 2023.
• Average Invested Capital over 5 years is $125.2 billion, with a median of $122.9 billion recorded in 2024.
• Year-over-year, Invested Capital dropped 21.21% in 2023 and climbed 28.57% in 2025.
• Over 5 years, Invested Capital stood at $111.0 billion in 2022, then dropped by 7.23% to $103.0 billion in 2023, then gained by 12.45% to $115.9 billion in 2024, then grew by 19.09% to $138.0 billion in 2025, then gained by 5.6% to $145.7 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $145.7 billion in Q2 2026, $153.6 billion in Q1 2026, and $138.0 billion in Q4 2025.